AbbVie Ready To Leverage Migraine Franchise In Crowded Market

Qulipta Adds Indication Not Covered By Botox, Ubrelvy

 
• By Mandy Jackson
Woman suffers migraine while standing in a crowd of people
AbbVie brings seventh CGRP inhibitor to crowded migraine market • Source: Alamy

More from New Products

More from Scrip